scholarly journals Growth hormone inhibition causes increased selenium levels in Duchenne muscular dystrophy: a possible new approach to therapy.

1984 ◽  
Vol 21 (4) ◽  
pp. 254-256 ◽  
Author(s):  
P J Collipp ◽  
J Kelemen ◽  
S Y Chen ◽  
M Castro-Magana ◽  
M Angulo ◽  
...  
Keyword(s):  
Growth Hormone ◽  
Duchenne Muscular Dystrophy ◽  
Muscular Dystrophy ◽  
New Approach

Growth Hormone Improves Growth in Duchenne Muscular Dystrophy Boys with Steroid-Induced Growth Failure.

2010 ◽  
pp. OR35-6-OR35-6 ◽  
Author(s):  
MM Rutter ◽  
J Collins ◽  
JG Woo ◽  
SR Rose ◽  
H Sawnani ◽  
...  
Keyword(s):  
Growth Hormone ◽  
Duchenne Muscular Dystrophy ◽  
Muscular Dystrophy ◽  
Growth Failure

P4.13 Growth hormone improves growth in Duchenne muscular dystrophy with steroid-induced growth failure

2010 ◽  
Vol 20 (9-10) ◽  
pp. 662
Author(s):  
J.J. Collins ◽  
M.M. Rutter ◽  
J. Woo ◽  
S. Rose ◽  
H. Sawnani ◽  
...  
Keyword(s):  
Growth Hormone ◽  
Duchenne Muscular Dystrophy ◽  
Muscular Dystrophy ◽  
Growth Failure

Treatment of duchenne muscular dystrophy with growth hormone inhibitors

1986 ◽  
Vol 24 (3) ◽  
pp. 549-566 ◽  
Author(s):  
Mayana Zatz ◽  
Roberto T. B. Betti ◽  
Oswaldo Frota-Pessoa ◽  
John M. Opitz ◽  
James F. Reynolds
Keyword(s):  
Growth Hormone ◽  
Duchenne Muscular Dystrophy ◽  
Muscular Dystrophy

Effect of mazindol on growth hormone levels in patients with Duchenne muscular dystrophy

1988 ◽  
Vol 31 (4) ◽  
pp. 821-833 ◽  
Author(s):  
Mayana Zatz ◽  
Debora Rapaport ◽  
Mariz Vainzof ◽  
Rita de Cassia M. Pavanello ◽  
Jane M. L. Rocha ◽  
...  
Keyword(s):  
Growth Hormone ◽  
Duchenne Muscular Dystrophy ◽  
Muscular Dystrophy ◽  
Hormone Levels

scholarly journals New Approach for Antisense Oligonucleotide-Mediated Exon Skipping in Duchenne Muscular Dystrophy

2012 ◽  
Vol 16 (4) ◽  
pp. 521-526
Author(s):  
Yoshitsugu Aoki ◽  
◽  
Tetsuya Nagata ◽  
Shin’ichi Takeda
Keyword(s):  
Duchenne Muscular Dystrophy ◽  
Muscular Dystrophy ◽  
Antisense Oligonucleotide ◽  
Antisense Oligonucleotides ◽  
Exon Skipping ◽  
New Approach ◽  
Reading Frame ◽  
Promising Therapeutic Approach ◽  
Dmd Gene ◽  
Dystrophin Protein

Duchenne Muscular Dystrophy (DMD) is a lethalmuscle disorder characterized by mutations in the DMD gene. These mutations primarily disrupt the reading frame, resulting in the absence of functional dystrophin protein. Exon skipping, which involves the use of antisense oligonucleotides is a promising therapeutic approach for DMD, and clinical trials on exon skipping are currently underway in DMD patients. Recently, stable and less-toxic antisense oligonucleotides with higher efficacy have been developed in mouse and dog models of DMD. This review highlights a new approach for antisense oligonucleotide-based therapeutics for DMD, particularly for exon skipping-based methods.

scholarly journals Metabolic Effects of Human Growth Hormone and of Estrogens in Boys with Duchenne Muscular Dystrophy

1972 ◽  
Vol 51 (5) ◽  
pp. 1118-1124 ◽  
Author(s):  
Daniel Rudman ◽  
Samuel B. Chyatte ◽  
Joseph H. Patterson ◽  
Glynda G. Gerron ◽  
Irma O'Beirne ◽  
...  
Keyword(s):  
Growth Hormone ◽  
Duchenne Muscular Dystrophy ◽  
Muscular Dystrophy ◽  
Human Growth Hormone ◽  
Human Growth ◽  
Metabolic Effects
Sign in / Sign up

Export Citation Format

Share Document